Intercept Pharmaceuticals, Inc.
ICPT · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $51 | $85 | $58 | $70 |
| Short-Term Investments | $435 | $335 | $412 | $583 |
| Receivables | $27 | $48 | $42 | $38 |
| Inventory | $0 | $0 | -$69 | $8 |
| Other Curr. Assets | $22 | $25 | $27 | $26 |
| Total Curr. Assets | $540 | $502 | $477 | $721 |
| Property Plant & Equip (Net) | $1 | $9 | $19 | $18 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $13 | $15 | $85 | $15 |
| Total NC Assets | $14 | $25 | $103 | $34 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $554 | $527 | $580 | $755 |
| Liabilities | – | – | – | – |
| Payables | $14 | $18 | $25 | $19 |
| Short-Term Debt | $110 | $3 | $7 | $6 |
| Tax Payable | $3 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $137 | $138 | $131 |
| Other Curr. Liab. | $106 | $9 | $9 | $6 |
| Total Curr. Liab. | $230 | $167 | $179 | $162 |
| LT Debt | $223 | $544 | $568 | $532 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $7 | $0 | $0 | $9 |
| Total NC Liab. | $231 | $544 | $568 | $541 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $7 | $15 | $6 |
| Total Liabilities | $461 | $711 | $747 | $703 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$2,137 | -$2,490 | -$2,398 | -$2,123 |
| AOCI | -$8 | -$3 | -$2 | -$1 |
| Other Equity | $2,238 | $2,309 | $2,234 | $2,176 |
| Total Equity | $93 | -$184 | -$167 | $52 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $554 | $527 | $580 | $755 |
| Net Debt | $282 | $463 | $517 | $468 |